Personalized medicine for non-small-cell lung cancer.
Kucherlapati
Raju
R
Departments of Genetics and Medicine, Harvard Medical School, Boston, Massachusetts, USA.
D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000235:genetics; D066246:ErbB Receptors / Q000037:antagonists & inhibitors* / Q000235:genetics; D005819:Genetic Markers; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000235:genetics; D057285:Precision Medicine; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*
D005819:Genetic Markers; D047428:Protein Kinase Inhibitors; D066246:ErbB Receptors